Get started
VERRICA PHARMACEUTICALS INCVERRICA PHARMACEUTICALS INCVERRICA PHARMACEUTICALS INC

VERRICA PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

1NE chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪339.86 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.62EUR
Net income (FY)
‪−60.70 M‬EUR
Revenue (FY)
‪4.64 M‬EUR
Shares float
‪25.77 M‬
Beta (1Y)
2.26

About Verrica Pharmaceuticals Inc.

Sector
Health Technology
CEO
Ted White
Headquarters
West Chester
Website
verrica.com
Employees (FY)
100
Founded
2013
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1NE is 8.04 EUR — it has increased by 1.01% in the past 24 hours. Watch VERRICA PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange VERRICA PHARMACEUTICALS INC stocks are traded under the ticker 1NE.
1NE stock has fallen by 8.38% compared to the previous week, the month change is a 24.07% rise, over the last year VERRICA PHARMACEUTICALS INC has showed a 43.57% increase.
We've gathered analysts' opinions on VERRICA PHARMACEUTICALS INC future price: according to them, 1NE price has a max estimate of 20.34 EUR and a min estimate of 11.09 EUR. Watch 1NE chart and read a more detailed VERRICA PHARMACEUTICALS INC stock forecast: see what analysts think of VERRICA PHARMACEUTICALS INC and suggest that you do with its stocks.
1NE reached its all-time high on Jun 27, 2018 with the price of 17.59 EUR, and its all-time low was 1.73 EUR and was reached on Jun 2, 2022. View more price dynamics on 1NE chart.
See other stocks reaching their highest and lowest prices.
1NE stock is 1.01% volatile and has beta coefficient of 2.26. Track VERRICA PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is VERRICA PHARMACEUTICALS INC there?
Today VERRICA PHARMACEUTICALS INC has the market capitalization of ‪339.86 M‬, it has increased by 1.16% over the last week.
Yes, you can track VERRICA PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
VERRICA PHARMACEUTICALS INC is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
1NE earnings for the last quarter are −0.41 EUR per share, whereas the estimation was −0.41 EUR resulting in a 1.55% surprise. The estimated earnings for the next quarter are −0.37 EUR per share. See more details about VERRICA PHARMACEUTICALS INC earnings.
VERRICA PHARMACEUTICALS INC revenue for the last quarter amounts to ‪3.55 M‬ EUR despite the estimated figure of ‪2.60 M‬ EUR. In the next quarter revenue is expected to reach ‪4.27 M‬ EUR.
1NE net income for the last quarter is ‪−18.84 M‬ EUR, while the quarter before that showed ‪−22.30 M‬ EUR of net income which accounts for 15.51% change. Track more VERRICA PHARMACEUTICALS INC financial stats to get the full picture.
No, 1NE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 22, 2024, the company has 100.00 employees. See our rating of the largest employees — is VERRICA PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERRICA PHARMACEUTICALS INC EBITDA is ‪−68.36 M‬ EUR, and current EBITDA margin is ‪−1.22 K‬%. See more stats in VERRICA PHARMACEUTICALS INC financial statements.
Like other stocks, 1NE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERRICA PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VERRICA PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VERRICA PHARMACEUTICALS INC stock shows the strong buy signal. See more of VERRICA PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.